Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network's MYLUNG Consortium.

Although not shown to be statistically significant, sites without the pharmacist intervention were analyzed during the same timeframe and showed a trend toward improvement in patient enrollment, from 3.2 to 4.9 patients per month ( p = .24) after the release of the weekly report.

also in 53,322 other papers